Weill Cornell Medicine received a $1.5 million grant to develop new approaches for predicting the spread of cancer cells to the bone in men with prostate cancer, using tumor samples taken at early stages of the disease.
The inaugural Inclusion and Belonging Summit was held on June 12, 2024 and hosted at Weill Cornell Medicine, drawing nearly 40 employees from Cornell’s main campus in Ithaca, Cornell Tech, Weill Cornell Medicine and other higher education institutions to New York City.
The transition to menopause is marked by a progressively higher density of estrogen receptors on brain cells, a measure that remains elevated in women up to their mid-60s, according to a new brain imaging study.
An artificial intelligence-powered method for detecting tumor DNA in blood has the potential to improve cancer care with the very early detection of recurrence and close monitoring of tumor response during therapy.
A new study helps explain how moving cells respond to environmental cues and set up internal structures that enable them to keep going in one direction during organ development, wound healing, cancer metastasis and many other processes
Researchers have discovered a link between two key pathways that regulate the immune system in mammals – a finding that impacts understanding of chronic inflammatory bowel diseases.
Changes that are longer-lasting and distinct between crew members reveal new targets for aerospace medicine and can guide new missions, according to the results of a massive international research endeavor.
By teasing out the biological mechanisms in pregnancy-related mental health disorders, investigators at Weill Cornell Medicine are laying the groundwork for new ways to detect and treat pregnant women and new mothers at risk.
Home health aides are vulnerable to stress, isolation and depressive symptoms, which impact their own health as well as their patients’ desire to age in place, according new research.
